ArticleSaudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
Primary orbital squamous cell carcinoma treated with definitive radiotherapy.
Article in Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Effective Treatment of Primary Orbital Squamous Cell Carcinoma with Radiotherapy: A Rare Case Report and Literature Review Update.Indian journal of surgical oncology · 2025Article
- Case Report: Primary Squamous Cell Carcinoma of the Orbit in a Patient With Carney's Syndrome Treated With Multidisciplinary Approaches.Cancer reports (Hoboken, N.J.) · 2024Article
- Confronting the Unseen: A Journey Through Primary Intra-orbital Squamous Cell Carcinoma.Cureus · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squamous cell carcinoma (SCC) arising from the orbit is a rare entity. Only a dozen of such cases are reported in the literature. Owing to its rarity, standard treatment is not defined, but most are treated with surgery. Herewith, we report the case of primary orbital SCC, in a 56-year-old female treated with radiotherapy (RT) alone, who presented with features of left-sided painful blind eye of 4 months' duration. Clinical and imaging studies pointed to no other possible primary malignancy elsewhere in the body, and a final diagnosis of locally advanced primary orbital SCC was made. The patient was treated with intensity-modulated RT, to a total dose of 66Gy in 33 fractions and completed the treatment with good pain relief. Response assessment imaging showed a complete response to treatment. At 2-year follow-up, the patient is alive, without disease and with normal vision in the unaffected eye. To conclude, primary orbital SCC is rare and can be treated successfully with RT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.